RESPA 787 (Respa-PE 600 mg / 18 mg)
Pill with imprint RESPA 787 is White, Elliptical / Oval and has been identified as Respa-PE 600 mg / 18 mg. It is supplied by Respa Pharmaceuticals.
Guaifenesin/phenylephrine is used in the treatment of cough and nasal congestion; sinus symptoms and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Guaifenesin/phenylephrine 600 mg / 18 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RESPA 787
Respa-PE
- Imprint
- RESPA 787
- Strength
- 600 mg / 18 mg
- Color
- White
- Shape
- Elliptical / Oval
- Availability
- Rx and/or OTC
- Drug Class
- Upper respiratory combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Respa Pharmaceuticals
- National Drug Code (NDC)
- 60575-0787 (Discontinued)
More about guaifenesin / phenylephrine
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- En Español
- 14 Reviews
- Drug class: upper respiratory combinations
Patient resources
- Drug Information
- Guaifenesin and Phenylephrine Drops
- Guaifenesin and Phenylephrine Liquid
- Guaifenesin and Phenylephrine Tablets
- Other brands
- Deconex, Donatussin Drops, Gilphex TR, Aldex G, ... +14 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.